Literature DB >> 30171207

Renoprotective effects of dulaglutide in patients with T2DM and CKD.

Charlotte M Sorensen1, Jens J Holst2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30171207     DOI： 10.1038/s41581-018-0055-x

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

Review 1.  Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?

Authors:  Yoshio Sumida; Masashi Yoneda; Hidenori Toyoda; Satoshi Yasuda; Toshifumi Tada; Hideki Hayashi; Yoichi Nishigaki; Yusuke Suzuki; Takafumi Naiki; Asahiro Morishita; Hiroshi Tobita; Shuichi Sato; Naoto Kawabe; Shinya Fukunishi; Tadashi Ikegami; Takaomi Kessoku; Yuji Ogawa; Yasushi Honda; Takashi Nakahara; Kensuke Munekage; Tsunehiro Ochi; Koji Sawada; Atsushi Takahashi; Taeang Arai; Tomomi Kogiso; Satoshi Kimoto; Kengo Tomita; Kazuo Notsumata; Michihiro Nonaka; Kazuhito Kawata; Taro Takami; Takashi Kumada; Eiichi Tomita; Takeshi Okanoue; Atsushi Nakajima
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.